Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research • 05/01/24
Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate DevelopmentsBusiness Wire • 05/01/24
Why Sarepta's First-Quarter Report Is Already Dead In The Water: AnalystInvestors Business Daily • 04/08/24
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 03/29/24
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street AnalystThe Motley Fool • 03/04/24
Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship ProgramBusiness Wire • 02/29/24
Sarepta Therapeutics (SRPT) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/29/24
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate DevelopmentsBusiness Wire • 02/28/24
Why Earnings Season Could Be Great for Sarepta Therapeutics (SRPT)Zacks Investment Research • 02/27/24
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial ResultsBusiness Wire • 02/21/24
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/20/24
Sarepta Therapeutics (SRPT) Moves 7.8% Higher: Will This Strength Last?Zacks Investment Research • 02/19/24